HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).

AuthorsJenny Bird, Judith Behrens, Jan Westin, Ingemar Turesson, Mark Drayson, Robert Beetham, Shirley D'Sa, Richard Soutar, Anders Waage, Nina Gulbrandsen, Henrik Gregersen, Eric Low, Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group
JournalBritish journal of haematology (Br J Haematol) Vol. 147 Issue 1 Pg. 22-42 (Oct 2009) ISSN: 1365-2141 [Electronic] England
PMID19673884 (Publication Type: Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Immunoglobulins
  • M-proteins (Myeloma)
Topics
  • Algorithms
  • Biomarkers (blood)
  • Cell Transformation, Neoplastic
  • Diagnosis, Differential
  • Disease Progression
  • Humans
  • Immunoglobulins (blood)
  • Long-Term Care (methods)
  • Lymphoproliferative Disorders (diagnosis)
  • Monoclonal Gammopathy of Undetermined Significance (diagnosis, epidemiology)
  • Multiple Myeloma (diagnosis)
  • Prognosis
  • Waldenstrom Macroglobulinemia (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: